Annual report
2342.TEDINET S100YCRI
Period2025-04-01 → 2026-03-31
Filed2026-06-17
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 141
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥13.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥13.1bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.4bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.6bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥138m | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | −¥260m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥118m | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥320m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥108m | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥199m | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥207m | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥676m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥77m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4m | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥410m | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥97m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | −¥1.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥9.7bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥9.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥9.8bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥10.7bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥10.4bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.9bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥4.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.8bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.0bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥6.1bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥6.6bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.6bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.1bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.5bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.5bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥4.6bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥26m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥94m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥392m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.4bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.8bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥51m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥288m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥281m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥216m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥982m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥518m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥265m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥343m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥485m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.2bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-4.64 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-65.51 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.24 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-24.32 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.52 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥109.31 | 2021-04-01 → 2022-03-31v | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥287.03 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥285.98 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥355.19 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥356.98 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥388.43 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 49.1% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.7% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.1% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.4% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.6% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 0.1% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 32.8% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 227 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 241 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 236 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 236 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 213 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥274m | 2025-04-01 → 2026-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥287m | 2024-04-01 → 2025-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥371m | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥397m | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥365m | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥2m | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | −¥20m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | −¥22m | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥37m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥87m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥73m | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥76m | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥462m | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | −¥484m | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | −¥1.2bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | −¥662m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥104m | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.7bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥5.5bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥6.4bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥6.9bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.0bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.6bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.3bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.8bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥4.3bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.7bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥5.9bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥6.7bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥6.8bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥459m | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥938m | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-29.06 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-69.35 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-39.41 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.17 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥158.3 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥158 | 2021-04-01 → 2022-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥3 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥6 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥256.26 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥280.14 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥353.18 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥394.96 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥406.51 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 76.9% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.4% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.4% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.4% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.6% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 48.3% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 16,999,141 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 16,999,141 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 16,999,141 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 16,999,141 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,369,141 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 6 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 5 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 6 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 6 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 7 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 57
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥1m |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥248,000 |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥7m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥7m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥2.6bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥177m |
| Drug Discovery Support Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥61m |
| Drug Discovery Support Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥71m |
| Drug Discovery Support Businessreportable segment | employees | at 2026-03-31 | 132 pure |
| Drug Discovery Support Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥2.3bn |
| Drug Discovery Support Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥2.3bn |
| Drug Discovery Support Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥6m |
| Drug Discovery Support Businessreportable segment | segment assets | at 2026-03-31 | ¥3.0bn |
| Drug Discovery Support Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥164m |
| Investments And Consulting Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥32m |
| Investments And Consulting Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥38m |
| Investments And Consulting Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥10.9bn |
| Investments And Consulting Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥10.9bn |
| Investments And Consulting Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥702,000 |
| Investments And Consulting Businessreportable segment | segment assets | at 2026-03-31 | ¥4.1bn |
| Investments And Consulting Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥480m |
| TGBS Businessreportable segment | employees | at 2026-03-31 | 89 pure |
| —segment total | employees | at 2026-03-31 | 221 pure |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥93m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥108m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥13.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥13.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥7.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥315m |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥1m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥1m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥6m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥2.8bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥210m |
| Drug Discovery Support Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥132m |
| Drug Discovery Support Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥102m |
| Drug Discovery Support Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Drug Discovery Support Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Drug Discovery Support Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥6m |
| Drug Discovery Support Businessreportable segment | segment assets | at 2025-03-31 | ¥3.1bn |
| Drug Discovery Support Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥488m |
| Investments And Consulting Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥135m |
| Investments And Consulting Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥36m |
| Investments And Consulting Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥11.1bn |
| Investments And Consulting Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥11.1bn |
| Investments And Consulting Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥438,000 |
| Investments And Consulting Businessreportable segment | segment assets | at 2025-03-31 | ¥3.6bn |
| Investments And Consulting Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥439m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥267m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥139m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥13.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥13.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥6m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥6.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | −¥50m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,436
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets | CurrentYearInstant_ValuationAndTranslationAdjustmentsMember | 139230000 | JPY |
| Net assets | CurrentYearInstant_SubscriptionRightsToSharesMember | 200000 | JPY |
| Net assets | CurrentYearInstant_NonControllingInterestsMember | 59592000 | JPY |
| Net assets | CurrentYearInstant | 4839789000 | JPY |
| Income before income taxes | Prior1YearDuration | -675959000 | JPY |
| Income before income taxes | CurrentYearDuration | -207439000 | JPY |
| Depreciation and amortization ope cf | Prior1YearDuration | 139586000 | JPY |
| Depreciation and amortization ope cf | CurrentYearDuration | 108475000 | JPY |
| Impairment loss ope cf | Prior1YearDuration | 228871000 | JPY |
| Impairment loss ope cf | CurrentYearDuration | 47072000 | JPY |
| Amortization of goodwill ope cf | Prior1YearDuration | 102210000 | JPY |
| Amortization of goodwill ope cf | CurrentYearDuration | 47128000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YearDuration | -5804000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYearDuration | -3368000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YearDuration | -5572000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYearDuration | -5012000 | JPY |
| Increase decrease in provision for loss on order received ope cf | Prior1YearDuration | 60327000 | JPY |
| Increase decrease in provision for loss on order received ope cf | CurrentYearDuration | 47409000 | JPY |
| Interest and dividends income ope cf | Prior1YearDuration | -1346000 | JPY |
| Interest and dividends income ope cf | CurrentYearDuration | -4075000 | JPY |
| Interest expenses ope cf | Prior1YearDuration | 36607000 | JPY |
| Interest expenses ope cf | CurrentYearDuration | 45759000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YearDuration | － | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYearDuration | -137520000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YearDuration | 10671000 | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYearDuration | － | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YearDuration | 211836000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYearDuration | 50951000 | JPY |
| Decrease increase in inventories ope cf | Prior1YearDuration | 12453000 | JPY |
| Decrease increase in inventories ope cf | CurrentYearDuration | -250653000 | JPY |
| Decrease increase in advance payments ope cf | Prior1YearDuration | -283120000 | JPY |
| Decrease increase in advance payments ope cf | CurrentYearDuration | -182209000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YearDuration | 49134000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYearDuration | 2162000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YearDuration | -166584000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYearDuration | -3314000 | JPY |
| Increase decrease in advances received ope cf | Prior1YearDuration | 365210000 | JPY |
| Increase decrease in advances received ope cf | CurrentYearDuration | 384979000 | JPY |
| Increase decrease in accrued expenses ope cf | Prior1YearDuration | 28194000 | JPY |
| Increase decrease in accrued expenses ope cf | CurrentYearDuration | 207811000 | JPY |
| Other net ope cf | Prior1YearDuration | -13843000 | JPY |
| Other net ope cf | CurrentYearDuration | -30667000 | JPY |
| Subtotal ope cf | Prior1YearDuration | 92874000 | JPY |
| Subtotal ope cf | CurrentYearDuration | 117488000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YearDuration | 1160000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYearDuration | 3492000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YearDuration | -36910000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYearDuration | -45275000 | JPY |
| Income taxes paid ope cf | Prior1YearDuration | -62081000 | JPY |
| Income taxes paid ope cf | CurrentYearDuration | -54073000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |